Cite
HARVARD Citation
Khanna, P. et al. (n.d.). THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal). Annals of the rheumatic diseases. pp. 382-383. [Online].